Jinhe Biotechnology CO., LTD. Stock

Equities

002688

CNE100001HK7

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-16 pm EDT 5-day change 1st Jan Change
5 CNY +4.38% Intraday chart for Jinhe Biotechnology CO., LTD. +5.04% +3.95%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2022 2.12B 294M Sales 2023 2.17B 301M Capitalization 3.63B 502M
Net income 2022 75M 10.38M Net income 2023 86M 11.91M EV / Sales 2022 2.35 x
Net Debt 2022 1.11B 154M Net Debt 2023 1.69B 234M EV / Sales 2023 2.45 x
P/E ratio 2022
53.1 x
P/E ratio 2023
43.4 x
Employees 2,292
Yield 2022
1.95%
Yield 2023
2.08%
Free-Float 53.64%
More Fundamentals * Assessed data
Dynamic Chart
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Jinhe Biotechnology CO., LTD.'s Equity Buyback Plan announced on February 6, 2024. CI
Jinhe Biotechnology CO., LTD. announces an Equity Buyback for CNY 100 million worth of its shares. CI
Jinhe Biotechnology CO., LTD. authorizes a Buyback Plan. CI
Jinhe Biotechnology Chairman Proposes Buyback of Up to 100 Million Yuan Shares MT
Jinhe Biotechnology Gets Nod for Live Brucellosis Vaccine MT
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Jinhe Biotechnology Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 05 June 2023 CI
Jinhe Biotechnology CO., LTD. announced that it expects to receive CAD 124.8 million in funding from Jinhe Youben Biological Products Co., Ltd. CI
Jinhe Biotechnology CO., LTD. Announces Board Election CI
Jinhe Biotechnology CO., LTD. Approves Cash Dividend (Tax Included) for 2022 CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jinhe Biotechnology Co., Ltd. Announces Final Profit Distribution Proposal for 2022 CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
More news
1 day+4.38%
1 week+5.04%
Current month+16.82%
1 month+44.51%
3 months+52.91%
6 months+2.46%
Current year+3.95%
More quotes
1 week
4.65
Extreme 4.65
5.00
1 month
3.52
Extreme 3.52
5.00
Current year
2.91
Extreme 2.91
5.00
1 year
2.91
Extreme 2.91
5.21
3 years
2.91
Extreme 2.91
7.51
5 years
2.91
Extreme 2.91
9.68
10 years
2.91
Extreme 2.91
13.28
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 98-12-31
Director of Finance/CFO 53 07-12-31
Director/Board Member 50 91-12-31
Members of the board TitleAgeSince
Director/Board Member 57 20-06-01
Director/Board Member 50 91-12-31
Chairman 72 -
More insiders
Date Price Change Volume
24-05-16 5 +4.38% 22 597 000
24-05-16 4.79 -1.84% 16,835,200
24-05-15 4.88 -0.81% 15,771,400
24-05-14 4.92 +2.50% 20,154,480
24-05-13 4.8 +3.23% 27,902,060

End-of-day quote Shenzhen S.E., May 16, 2024

More quotes
Jinhe Biotechnology CO., LTD. is a China-based company principally engaged in the research, development, production and sale of pharmaceutical feed additives. The Company's main products include animal feed additives, veterinary drug additives, veterinary vaccines and veterinary drugs. The Company is also involved in processing of corn starch, as well as wastewater treatment business. The Company distributes its products in domestic market and to overseas markets.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 002688 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW